Skip to content
ppharmaranks
Menu
Class ICompleted

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free recall

FDA recall D-0508-2024 · initiated Apr 29, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 29, 2024How we research

Hikma Injectables USA Inc recalled Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free in Apr 2024 — an FDA Class I recall (D-0508-2024) because Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 240310003D, Exp 6/4/2024

Details

Product
Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25
Recalling company
Hikma Injectables USA Inc
Classification
Class I
Status
Completed
Type
Voluntary: Firm initiated
Distribution
CO, GA, PA, SD, WA
Initiated
Apr 29, 2024
FDA report date
May 29, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free recalled?
Hikma Injectables USA Inc recalled Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free in Apr 2024 — an FDA Class I recall (D-0508-2024) because Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free recalled?
Per the FDA enforcement record, the reason for recall D-0508-2024 was: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Is a recalled Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free are affected?
Distributed: CO, GA, PA, SD, WA. The recall covers these lots — Lot #: 240310003D, Exp 6/4/2024. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0508-2024.

Source: openFDA Drug Enforcement record D-0508-2024

← All drug recalls